chrysin is a characteristic flavonoid right now under scrutiny because of its significant organic enemy of malignant growth properties. In a large portion of the disease cells tried, chrysin has appeared to restrain expansion and incite apoptosis, and is more powerful than other tried flavonoids in leukemia cells, where chrysin is probably going to act by means of actuation of caspases and inactivation of Akt motioning in the cells. Also, structure-movement connections have uncovered that the synthetic structure of chrysin meets the key auxiliary necessities of flavonoids for strong cytotoxicity in leukemia cells. It is conceivable that blend treatment or adjusted chrysin could be more strong than single-specialist use or organization of unmodified chrysin
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Research Article: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Advanced Practices in Nursing
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report